SCR-LIP-000221 · Claim · machine-readable JSON →

This integrative review proposes that menopause acts as a critical inflection point in lipedema progression via estrogen receptor imbalance (downregulated ERα and upregulated ERβ in affected tissue), increased local intracrine estradiol production through elevated aromatase (CYP19A1) and 17β-HSD1 with deficient 17β-HSD2, and progesterone resistance, reframing lipedema as an estrogen-dependent disorder.

Emerging clinical association Evidence certainty: very low (GRADE)

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2025Menopause as a Critical Turning Point in Lipedema: The Estrogen Receptor Imbalance, Intracrine Estrogen, and Adipose Tissue Dysfunction Model — Pinto da Costa Viana et al. (2025) · supporting

Evidence (1)

Context (PECO)

Conditionlipedema
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Hypothesis/model paper (narrative review), not primary evidence; light-review venue. Treat as mechanistic context, not as establishing the association.

Change log